The Multiple Myeloma Drug Pipeline—2018: A Review of Small Molecules and Their Therapeutic Targets

Share "The Multiple Myeloma Drug Pipeline—2018: A Review of Small Molecules and Their Therapeutic Targets"

N/A

Protected

Studieår: 2022

Info

Protected

Academic year: 2022

Share "The Multiple Myeloma Drug Pipeline—2018: A Review of Small Molecules and Their Therapeutic Targets"

Copied!

Fulltekst

Referanser

RELATERTE DOKUMENTER

$Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma$